Effect of Adoption of Neoadjuvant Chemotherapy for Advanced Ovarian Cancer on All Cause Mortality: Quasi-Experimental Study

British Medical Journal - United Kingdom
doi 10.1136/bmj.j5463
Full Text
Abstract

Available in full text

Categories
Medicine
Date
Authors
Publisher

BMJ

Related search

Neoadjuvant Chemotherapy for Advanced Epithelial Ovarian Cancer. Who Really Benefits?

Australian and New Zealand Journal of Obstetrics and Gynaecology
MedicineGynecologyObstetrics
2017English

Evaluating the Benefits of Neoadjuvant Chemotherapy for Advanced Epithelial Ovarian Cancer: A Retrospective Study

Journal of Ovarian Research
GynecologyOncologyObstetrics
2019English

Neoadjuvant Chemotherapy for Patients With Advanced Epithelial Ovarian Cancer: A Meta-Analysis

Scientific Reports
Multidisciplinary
2016English

Neoadjuvant Chemotherapy of Resectable Advanced Gastric Cancer

Nihon Gekakei Rengo Gakkaishi (Journal of Japanese College of Surgeons)
2012English

Neoadjuvant Chemotherapy in Advanced Ovarian Cancer: Latest Results and Place in Therapy

Therapeutic Advances in Medical Oncology
Oncology
2014English

Correction: Neighbourhood Socioeconomic Position and Risks of Major Chronic Diseases and All-Cause Mortality: A Quasi-Experimental Study

BMJ Open
Medicine
2019English

Primary Debulking Surgery Versus Primary Neoadjuvant Chemotherapy for High Grade Advanced Stage Ovarian Cancer: Comparison of Survivals

Radiology and Oncology
Nuclear MedicineRadiologyImagingOncology
2018English

Neoadjuvant Chemotherapy in the Management of Advanced Ovarian Cancer and Primary Cancer of the Peritoneum: Rationale and Results

2013English

Outcomes of Non-High Grade Serous Carcinoma After Neoadjuvant Chemotherapy for Advanced-Stage Ovarian Cancer: A Korean Gynecologic Oncology Group Study (OV 1708)

BMC Cancer
Cancer ResearchOncologyGenetics
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy